Related Experiment Video
Updated: Jul 21, 2026

08:52
Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells
Published on: June 13, 2018
8.8K
Constructing a Nomogram for Predicting Pelvic Osteosarcoma: A Retrospective Study Based on the SEER Database and a
Yefeng Xu1, Qingying Yan1, Jiewen Yang1
1Department of Oncology, Hangzhou Third People's Hospital, Hangzhou, Zhejiang, China.
British Journal of Hospital Medicine (London, England : 2005)
|August 30, 2024
Summary
This study developed a new nomogram to predict survival for pelvic osteosarcoma patients. The tool accurately forecasts outcomes based on factors like age, tumor size, and lung metastasis, aiding clinical decisions.
Area of Science:
- Oncology
- Surgical Oncology
- Biostatistics
Background:
- Pelvic osteosarcoma generally has a poorer prognosis than limb osteosarcoma.
- Accurate prognostic prediction is crucial for effective treatment planning in pelvic osteosarcoma.
- Existing prognostic models may not adequately address the specific characteristics of pelvic osteosarcoma.
Purpose of the Study:
- To develop and validate a novel nomogram for predicting the overall survival of patients diagnosed with pelvic osteosarcoma.
- To identify independent prognostic factors influencing survival in pelvic osteosarcoma.
- To improve clinical decision-making and patient management for this rare cancer.
Main Methods:
- Retrospective analysis of clinical data from 62 patients in the SEER database (training cohort) and 31 Chinese patients (validation cohort).
- Kaplan-Meier survival analysis to determine median survival times for various factors.
- Univariate and multivariate Cox regression models to identify independent prognostic factors.
- Construction and validation of a predictive nomogram using ROC curves and calibration plots.
Main Results:
- Key prognostic factors identified include age, race (Asian), tumor size, primary surgery status, lung metastasis, and radiotherapy.
- Multivariate analysis confirmed age, lung metastasis, race (Asian), and tumor size as independent predictors.
- The developed nomogram demonstrated good predictive accuracy in both training (AUCs: 0.81-0.80) and validation (AUCs: 0.67-0.71) cohorts for 1-3 year survival rates.
Conclusions:
- The newly developed nomogram provides a reliable tool for predicting overall survival in patients with pelvic osteosarcoma.
- This predictive model can assist clinicians in making more informed treatment decisions and tailoring patient care.
- Further validation in larger, diverse populations may enhance the nomogram's generalizability.

